Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 1, 2005, Pages 62-69

  Terhaard, Chris H J ^a   Kal, Henk B ^a   Hordijk, Gerrit Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Accelerated fractionation; Laryngeal cancer; Local control; Repopulation; Toxicity

Indexed keywords

CELLS; DISEASES; DRUG DOSAGE; PATIENT TREATMENT; PROBABILITY; TOXICITY; TUMORS;

LARYNGEAL CANCER; MUCOSITIS; TRACHEOTOMY; TUMOR CELLS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CONTROL; CONTROLLED STUDY; DYSPNEA; FEMALE; FOLLOW UP; FRACTIONATION; HUMAN; LARYNX CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SAFETY; STATISTICAL ANALYSIS; STRIDOR; TRACHEOTOMY;

EID: 17844393098     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.09.007     Document Type: Article

References (33)

1. R.G. Wiggenraad, C.H.J. Terhaard, G.J. Hordijk The importance of vocal cord mobility in T2 laryngeal cancer Radiother Oncol 18 1990 321 327
2. C.H.J. Terhaard, A.B.M.F. Karim, W.J. Hoogenraad Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship The concept of NSD and LQ model Int J Radiat Oncol Biol Phys 21 1991 1207 1214
3. K.K. Fu, T.F. Pajak, A. Trotto A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
4. S.M. Jackson, L.M. Weir, J.H. Hay A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer Radiother Oncol 43 1997 39 46
5. H.R. Withers, J.M.G. Taylor, B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
6. B. Jones, R.G. Dale Mathematical models of tumor and normal tissue response Acta Oncol 38 1999 883 893
7. R.M. Wyatt, A.H. Beddoe, R.G. Dale The effects of delays in radiotherapy treatment on tumor control Phys Med Biol 48 2003 139 155
8. G.G. Steel Basic clinical radiobiology 3rd ed. 2002 Arnold London
9. G.W. Barendsen Dose fractionation, dose rate and iso-effect relationships for normal tissue responses Int J Radiat Oncol Biol Phys 8 1982 1981 1997
10. M.B. Barton, T.J. Keane, T. Gadalla The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer Radiother Oncol 23 1992 137 143
11. J. Overgaard, H.S. Hansen, M. Specht Lovergaard Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck DAHANCA 6&7 randomized controlled trial Lancet 362 2003 933 940
12. K. Skladowski, B. Maciejewski, M. Golen Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer--report on 3-year tumor control and normal tissue toxicity Radiother Oncol 55 2000 101 110
13. J.C. Horiot, P. Bontemps, W. Bogaert van den Accelerated fractionation (AF) compared with conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121
14. T.D. Nguyen, X. Panis, M. Legros Hyperfractionated radiotherapy in advanced squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 9 1983 393 395
15. M.G. Poulsen, J.W. Denham, L.J. Peters A randomized trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck A Trans-Tasman Radiation Oncology Group Study Radiother Oncol 60 2001 113 122
16. S. Dische, M. Saunders, A. Barrett A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
17. W. Bogaert van den, E. Schueren van der, J.C. Horiot The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer Long-term results and side effects Radiother Oncol 35 1995 91 99
18. K.K. Fu, T.F. Pajak, V.A. Marcial Late effects of hyperfractionated radiotherapy for advanced head and neck cancer Long-term follow-up results of RTOG 83-13 Int J Radiat Oncol Biol Phys 32 1995 577 588
19. A. Trotti Toxicity in head and neck cancer A review of trends and issues Int J Radiat Oncol Biol Phys 47 2000 1 12
20. J.F. Fowler, P.M. Harari, F. Leborgne Acute radiation reactions in oral and pharyngeal mucosa Tolerable levels in altered fractionation schedules Radiother Oncol 69 2003 161 168
21. E. Schueren van der, W. Bogaert van den, L. Vanuytsel Radiotherapy by multiple fractions per day (MFD) in head and neck cancer Acute reactions of skin and mucosa Int J Radiat Oncol Biol Phys 19 1991 301 311
22. H.D. Thames, S.M. Bentzen Time factor for tonsillar carcinoma Int J Radiat Oncol Biol Phys 33 1995 755 758
23. S.M. Bentzen, M.I. Saunders, S. Dische Radiotherapy-related early morbidity in head and neck cancer Quantitative clinical radiobiology as deduced from the CHART trial Radiother Oncol 60 2001 123 135
24. R. Schmidt-Ullrich, J.C.R. Johnson, D.E. Wazer Accelerated superfractionation for advanced carcinoma of the head and neck Concomitant boost technique Int J Radiat Oncol Biol Phys 19 Suppl. 1 1990 142
25. S.A. Roberts, J.H. Hendry The delay before onset of accelerated tumor cell repopulation A direct maximum-likelihood analysis of a collection of worldwide tumor-control data Radiother Oncol 29 1993 69 74
26. S.A. Roberts, J.H. Hendry, N.J. Slevin Modeling the optimal radiotherapy regimen for the control of T2 laryngeal carcinoma using parameters derived from several datasets Int J Radiat Oncol Biol Phys 39 1997 1173 1182
27. R. Tarnawski, J.F. Fowler, K. Skladowski How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys 54 2002 229 236
28. J.W. Denham, L.J. Peters, J. Johanssen Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52 1999 157 164
29. J.H.A.M. Kaanders, L.A. Pop, H.A.M. Marres ARCON Experience in 215 patients with advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 52 2002 769 778
30. B.M. Nakfoor, I.J. Spiro, C.C. Wang Results of accelerated radiotherapy for supraglottic carcinoma A Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience Head Neck 20 1998 379 384
31. R. MacKenzie, E. Franssen, J. Balogh The prognostic significance of tracheotomy in carcinoma of the larynx treated with radiotherapy and surgery for salvage Int J Radiat Oncol Biol Phys 41 1998 43 51
32. C.H.J. Terhaard, K. Snippe, L.A. Ravasz Radiotherapy in T1 laryngeal cancer Prognostic factors for locoregional control, uni- and multivariate analysis Int J Radiat Oncol Biol Phys 21 1991 1179 1186
33. G.P. Brownman, G. Wong, I. Hodson Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer N Engl J Med 328 1993 159 163